Product Description
Recombinant Streptokinase For Injection IP is a highly effective general medicine formulated for the treatment of thrombolytic conditions. Presented in liquid form, it is suitable for adult patients and is designed for intravenous administration. With a potent dosage of 1,500,000 IU, this product provides immediate and efficient action against blood clots. Each 5 ml vial is conveniently packaged for distribution, trading, and export purposes, ensuring ease of handling and storage. It is recommended to store the product at room temperature to maintain stability and efficacy. The injectable solution delivers precision and reliability, making it an ideal choice for medical practitioners managing cardiovascular emergencies.
FAQs of Recombinant Streptokinase For Injection IP: